Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa

Abstract Background Colistin is a last resort antibiotic for the treatment of carbapenem-resistant Gram negative infections. Until recently, mechanisms of colistin resistance were limited to chromosomal mutations which confer a high fitness cost and cannot be transferred between organisms. However,...

Full description

Bibliographic Details
Main Authors: Mae Newton-Foot, Yolandi Snyman, Motlatji Reratilwe Bonnie Maloba, Andrew Christopher Whitelaw
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Antimicrobial Resistance and Infection Control
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13756-017-0234-8
_version_ 1818111594509369344
author Mae Newton-Foot
Yolandi Snyman
Motlatji Reratilwe Bonnie Maloba
Andrew Christopher Whitelaw
author_facet Mae Newton-Foot
Yolandi Snyman
Motlatji Reratilwe Bonnie Maloba
Andrew Christopher Whitelaw
author_sort Mae Newton-Foot
collection DOAJ
description Abstract Background Colistin is a last resort antibiotic for the treatment of carbapenem-resistant Gram negative infections. Until recently, mechanisms of colistin resistance were limited to chromosomal mutations which confer a high fitness cost and cannot be transferred between organisms. However, a novel plasmid-mediated colistin resistance mechanism, encoded by the mcr-1 gene, has been identified, and has since been detected worldwide. The mcr-1 colistin resistance mechanism is a major threat due to its lack of fitness cost and ability to be transferred between strains and species. Surveillance of colistin resistance mechanisms is critical to monitor the development and spread of resistance.This study aimed to determine the prevalence of the plasmid-mediated colistin resistance gene, mcr-1, in colistin-resistant E. coli and Klebsiella spp. isolates in the Western Cape of South Africa; and whether colistin resistance is spread through clonal expansion or by acquisition of resistance by diverse strains. Methods Colistin resistant E. coli and Klebsiella spp. isolates were collected from the NHLS microbiology laboratory at Tygerberg Hospital. Species identification and antibiotic susceptibility testing was done using the API® 20 E system and the Vitek® 2 Advanced Expert System™. PCR was used to detect the plasmid-mediated mcr-1 colistin resistance gene and REP-PCR was used for strain typing of the isolates. Results Nineteen colistin resistant isolates, including 12 E. coli, six K. pneumoniae and one K. oxytoca isolate, were detected over 7 months from eight different hospitals in the Western Cape region. The mcr-1 gene was detected in 83% of isolates which were shown to be predominantly unrelated strains. Conclusions The plasmid-mediated mcr-1 colistin resistance gene is responsible for the majority of colistin resistance in clinical isolates of E. coli and Klebsiella spp. from the Western Cape of South Africa. Colistin resistance is not clonally disseminated; the mcr-1 gene has been acquired by several unrelated strains of E. coli and K. pneumoniae. Acquisition of mcr-1 by cephalosporin- and carbapenem-resistant Gram negative bacteria may result in untreatable infections and increased mortality. Measures need to be implemented to control the use of colistin in health care facilities and in agriculture to retain its antimicrobial efficacy.
first_indexed 2024-12-11T03:05:32Z
format Article
id doaj.art-b21ba7438e834099963232d9703eec7b
institution Directory Open Access Journal
issn 2047-2994
language English
last_indexed 2024-12-11T03:05:32Z
publishDate 2017-08-01
publisher BMC
record_format Article
series Antimicrobial Resistance and Infection Control
spelling doaj.art-b21ba7438e834099963232d9703eec7b2022-12-22T01:22:58ZengBMCAntimicrobial Resistance and Infection Control2047-29942017-08-01611710.1186/s13756-017-0234-8Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South AfricaMae Newton-Foot0Yolandi Snyman1Motlatji Reratilwe Bonnie Maloba2Andrew Christopher Whitelaw3Division of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch UniversityDivision of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch UniversityDivision of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch UniversityDivision of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch UniversityAbstract Background Colistin is a last resort antibiotic for the treatment of carbapenem-resistant Gram negative infections. Until recently, mechanisms of colistin resistance were limited to chromosomal mutations which confer a high fitness cost and cannot be transferred between organisms. However, a novel plasmid-mediated colistin resistance mechanism, encoded by the mcr-1 gene, has been identified, and has since been detected worldwide. The mcr-1 colistin resistance mechanism is a major threat due to its lack of fitness cost and ability to be transferred between strains and species. Surveillance of colistin resistance mechanisms is critical to monitor the development and spread of resistance.This study aimed to determine the prevalence of the plasmid-mediated colistin resistance gene, mcr-1, in colistin-resistant E. coli and Klebsiella spp. isolates in the Western Cape of South Africa; and whether colistin resistance is spread through clonal expansion or by acquisition of resistance by diverse strains. Methods Colistin resistant E. coli and Klebsiella spp. isolates were collected from the NHLS microbiology laboratory at Tygerberg Hospital. Species identification and antibiotic susceptibility testing was done using the API® 20 E system and the Vitek® 2 Advanced Expert System™. PCR was used to detect the plasmid-mediated mcr-1 colistin resistance gene and REP-PCR was used for strain typing of the isolates. Results Nineteen colistin resistant isolates, including 12 E. coli, six K. pneumoniae and one K. oxytoca isolate, were detected over 7 months from eight different hospitals in the Western Cape region. The mcr-1 gene was detected in 83% of isolates which were shown to be predominantly unrelated strains. Conclusions The plasmid-mediated mcr-1 colistin resistance gene is responsible for the majority of colistin resistance in clinical isolates of E. coli and Klebsiella spp. from the Western Cape of South Africa. Colistin resistance is not clonally disseminated; the mcr-1 gene has been acquired by several unrelated strains of E. coli and K. pneumoniae. Acquisition of mcr-1 by cephalosporin- and carbapenem-resistant Gram negative bacteria may result in untreatable infections and increased mortality. Measures need to be implemented to control the use of colistin in health care facilities and in agriculture to retain its antimicrobial efficacy.http://link.springer.com/article/10.1186/s13756-017-0234-8Colistin resistancemcr-1plasmid-mediated resistanceE. coliKlebsiella sppSouth Africa
spellingShingle Mae Newton-Foot
Yolandi Snyman
Motlatji Reratilwe Bonnie Maloba
Andrew Christopher Whitelaw
Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa
Antimicrobial Resistance and Infection Control
Colistin resistance
mcr-1
plasmid-mediated resistance
E. coli
Klebsiella spp
South Africa
title Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa
title_full Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa
title_fullStr Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa
title_full_unstemmed Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa
title_short Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa
title_sort plasmid mediated mcr 1 colistin resistance in escherichia coli and klebsiella spp clinical isolates from the western cape region of south africa
topic Colistin resistance
mcr-1
plasmid-mediated resistance
E. coli
Klebsiella spp
South Africa
url http://link.springer.com/article/10.1186/s13756-017-0234-8
work_keys_str_mv AT maenewtonfoot plasmidmediatedmcr1colistinresistanceinescherichiacoliandklebsiellasppclinicalisolatesfromthewesterncaperegionofsouthafrica
AT yolandisnyman plasmidmediatedmcr1colistinresistanceinescherichiacoliandklebsiellasppclinicalisolatesfromthewesterncaperegionofsouthafrica
AT motlatjireratilwebonniemaloba plasmidmediatedmcr1colistinresistanceinescherichiacoliandklebsiellasppclinicalisolatesfromthewesterncaperegionofsouthafrica
AT andrewchristopherwhitelaw plasmidmediatedmcr1colistinresistanceinescherichiacoliandklebsiellasppclinicalisolatesfromthewesterncaperegionofsouthafrica